A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
Public ClinicalTrials.gov record NCT07759154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Multicenter, Open-label, Single-arm Trial to Evaluate the Efficacy and Safety of Orally Administered Centanafadine QD XR Capsules in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to evaluate the efficacy of centanafadine once daily (QD) extended-release (XR) capsules in adults with attention-deficit/hyperactivity disorder (ADHD) and emotional dysregulation (ED).
Study identification
- NCT ID
- NCT07759154
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 80 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2026
- Primary completion
- May 26, 2027
- Completion
- May 26, 2027
- Last update posted
- Sep 13, 2026
2026 – 2027
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sarkis Clinical Trials - Gainesville | Gainesville | Florida | 32607 | Not yet recruiting |
| CNS Healthcare - Jacksonville (Clinical Neuroscience Solutions - Jacksonville) | Jacksonville | Florida | 32256 | Not yet recruiting |
| Accel Research Sites-Maitland | Maitland | Florida | 32751 | Not yet recruiting |
| Nola Research Works | New Orleans | Louisiana | 70125 | Recruiting |
| Boston Clinical Trials | Boston | Massachusetts | 02132 | Not yet recruiting |
| Adams Clinical - Watertown | Watertown | Massachusetts | 02472 | Not yet recruiting |
| St. Charles Psychiatric Associates/Midwest Research Group | Saint Charles | Missouri | 63304 | Not yet recruiting |
| Center for Psychiatry and Behavioral Medicine. Inc. | Las Vegas | Nevada | 89128 | Not yet recruiting |
| Center for Emotional Fitness | Cherry Hill | New Jersey | 08002 | Recruiting |
| The Medical Research Network, LLC | New York | New York | 10128 | Not yet recruiting |
| Patient Priority Clinical Trials | Cincinnati | Ohio | 45215 | Not yet recruiting |
| Summit Research Network | Portland | Oregon | 97210 | Recruiting |
| Donald J. Garcia, Jr, MD, PA | Austin | Texas | 78737 | Recruiting |
| Houston Clinical Trials LLC | Bellaire | Texas | 77401 | Recruiting |
| Kaleidoscope Clinical Research | Houston | Texas | 77089 | Not yet recruiting |
| Core Clinical Research | Everett | Washington | 98201 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07759154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 13, 2026 · Synced Sep 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07759154 live on ClinicalTrials.gov.